facebook tracking

Sarcoma Free Patient Webinar Header

Free Patient Webinar

Know What Your Doctors Know: Soft Tissue Sarcoma

Two chances to attend!

  • Tuesday, June 11, 2019 10:00 to 11:15 AM ET

    Register Now

  • Wednesday, June 12, 2019 4:30 to 5:45 PM ET

    Register Now

Join experts as they discuss treatment of soft tissue sarcoma. This webinar is designed to help participants:

  • Demonstrate an understanding of what soft tissue sarcoma is, and how it is diagnosed and staged
  • Compare, discuss, and select treatment options with their doctor
  • Discover the most recent advancements in soft tissue sarcoma care
  • Identify and utilize supportive care and patient and caregiver resources

Each webinar will also include a Question & Answer session. You may submit questions to the presenters during the webinar or in advance. Register for more details.

Agenda

  • Introduction
  • Expert Discussion of Soft Tissue Sarcoma
  • Question & Answer Session

Click here for a printer-friendly flyer.

Presenters

  • Margaret von Mehren, MD
    Chief, Division of Sarcoma Medical Oncology
    Physician Director, Clinical Trials Operations
    Associate Director, Clinical Research
    Fox Chase Cancer Center
  • Nancy Stoots, RN, BSN, OCN
    Registered Nurse, Outpatient Department
    Fox Chase Cancer Center
  • Denise Reinke, MS, NP, MBA
    President and CEO
    SARC (Sarcoma Alliance for Research through Collaboration)

Intended Audience

This event is designed for people with soft tissue sarcoma, their caregivers, and their families.

Please note: This is a non-accredited activity.

Fee Information

Webinars are free to attend. Also, a free copy of the NCCN Guidelines for Patients®: Soft Tissue Sarcoma, Version 2018 will be sent to the first 200 registrants to request a book. The NCCN Guidelines for Patients are a patient-friendly version of the NCCN Clinical Practice Guidelines in Oncology. They are a good starting point to learn the best health care options for a type of cancer.

Supporters

This activity is supported through the NCCN Foundation, by a contribution from our industry supporter Lilly and Company. NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein.

The NCCN Guidelines for Patients: Soft Tissue Sarcoma are endorsed and sponsored in part by:

SARC (Sarcoma Alliance for Research through Collaboration)